1
|
Ma ZH, Ma XN, Zhu HW, Cheng L, Gou LZ, Zhang DK. Clinical significance of peripheral blood DDR1 and CtBP gene methylation detection in patients with acute pancreatitis. Epigenetics 2024; 19:2421631. [PMID: 39485950 PMCID: PMC11540100 DOI: 10.1080/15592294.2024.2421631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2024] [Revised: 09/03/2024] [Accepted: 10/22/2024] [Indexed: 11/03/2024] Open
Abstract
To investigate the clinical value of methylation levels of peripheral blood DDR1 and CtBP genes in evaluating the severity of acute pancreatitis (AP). Collect 90 blood samples from AP patients and healthy volunteers, and test methylation levels of SPINK1, STAT3, KIT, CFTR, DDR1, CtBP1, CtBP2 genes by bisulfite amplicon sequencing (BSAS). The gene methylation and clinical predictors of SAP early prediction were determined by univariate and multifactorial analysis, respectively. (1) The methylation level of CtBP1 gene and MCTSI score were independent predictors of SAP, with AUC values of 0.723 and 0.8895, respectively. (2) The methylation levels of DDR1, CtBP2, CFTR and SPINK1 genes were statistically significant in HC group vs AP group, HC group vs MAP group, and HC group vs SAP group. (3) The combined detection of CtBP1 gene methylation level and MCTSI score predicted the sensitivity, specificity, AUC, and 95%CI of SAP were 0.750, 0.957, 0.902, and 0.816-0.989, respectively. (1) The methylation level of CtBP1 gene in peripheral blood is an independent risk factor for predicting SAP and is a potentially good predictor of SAP, and the combined testing with the MCTSI score does not further significantly improve the early predictive value for SAP. (2) The methylation levels of DDR1, SPINK1, CtBP2, and CFTR genes were potential indicators for recognizing AP.
Collapse
Affiliation(s)
- Zeng-Hui Ma
- The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
- Department of Gastroenterology, Lanzhou University Second Hospital, Lanzhou, Gansu, China
- Key laboratory of Digestive Diseases, Lanzhou University Second Hospital, Lanzhou, Gansu, China
| | - Xue-Ni Ma
- The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
- Department of Gastroenterology, Lanzhou University Second Hospital, Lanzhou, Gansu, China
- Key laboratory of Digestive Diseases, Lanzhou University Second Hospital, Lanzhou, Gansu, China
| | - Hong-Wen Zhu
- The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
- Department of Gastroenterology, Lanzhou University Second Hospital, Lanzhou, Gansu, China
- Key laboratory of Digestive Diseases, Lanzhou University Second Hospital, Lanzhou, Gansu, China
- Cuiying Biomedical Research Center, Lanzhou University Second Hospital, Lanzhou, Gansu, China
| | - Long Cheng
- The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
- Department of Gastroenterology, Lanzhou University Second Hospital, Lanzhou, Gansu, China
- Key laboratory of Digestive Diseases, Lanzhou University Second Hospital, Lanzhou, Gansu, China
| | - Ling-Zhu Gou
- The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
- Department of Gastroenterology, Lanzhou University Second Hospital, Lanzhou, Gansu, China
- Key laboratory of Digestive Diseases, Lanzhou University Second Hospital, Lanzhou, Gansu, China
| | - De-Kui Zhang
- Department of Gastroenterology, Lanzhou University Second Hospital, Lanzhou, Gansu, China
- Key laboratory of Digestive Diseases, Lanzhou University Second Hospital, Lanzhou, Gansu, China
| |
Collapse
|
2
|
Zhou L, Yu J, Wang S, Ma Y, Liu X, Zhang X, Luo Y, Wen S, Li L, Li W, Niu X. Tectoridin alleviates caerulein-induced severe acute pancreatitis by targeting ERK2 to promote macrophage M2 polarization. Arch Biochem Biophys 2024; 752:109873. [PMID: 38141907 DOI: 10.1016/j.abb.2023.109873] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2023] [Revised: 12/07/2023] [Accepted: 12/16/2023] [Indexed: 12/25/2023]
Abstract
Severe acute pancreatitis (SAP) is an inflammatory disease of the pancreas with a high mortality rate. Macrophages play a crucial role in the pathogenesis of pancreatitis. Tectoridin (Tec) is a highly active isoflavone with anti-inflammatory pharmacological activity. However, the role of Tec in the SAP process is not known. The purpose of this study was to investigate the therapeutic effect and potential mechanism of Tec on SAP. To establish SAP mice by intraperitoneal injection of caerulein and Lipopolysaccharide (LPS), the role of Tec in the course of SAP was investigated based on histopathology, biochemical indicators of amylase and lipase and inflammatory factors. The relationship between Tec and macrophage polarization was verified by immunofluorescence, real-time quantitative PCR and Western blot analysis. We then further predicted the possible targets and signal pathways of action of Tec by network pharmacology and molecular docking, and validated them by in vivo and in vitro. In this study, we demonstrated that Tec significantly reduced pancreatic injury in SAP mice, and decreased serum levels of amylase and lipase. The immunofluorescence and Western blot analysis showed that Tec promoted macrophage M2 polarization. Network pharmacology and molecular docking predicted that Tec may target ERK2 for the treatment of SAP, and in vivo and in vitro experiments proved that Tec inhibited the ERK MAPK signal pathway. In summary, Tec can target ERK2, promote macrophage M2 polarization and attenuate pancreatic injury, Tec may be a potential drug for the treatment of SAP.
Collapse
Affiliation(s)
- Lili Zhou
- School of Pharmacy, Xi'an Jiaotong University, Xi'an, PR China
| | - Jinjin Yu
- School of Pharmacy, Xi'an Jiaotong University, Xi'an, PR China
| | - Siqi Wang
- School of Pharmacy, Xi'an Jiaotong University, Xi'an, PR China
| | - Yajing Ma
- School of Pharmacy, Xi'an Jiaotong University, Xi'an, PR China
| | - Xinyao Liu
- School of Pharmacy, Xi'an Jiaotong University, Xi'an, PR China
| | - Xinya Zhang
- School of Pharmacy, Xi'an Jiaotong University, Xi'an, PR China
| | - Yuzhi Luo
- School of Pharmacy, Xi'an Jiaotong University, Xi'an, PR China
| | - Sha Wen
- School of Pharmacy, Xi'an Jiaotong University, Xi'an, PR China
| | - Lingli Li
- School of Pharmacy, Xi'an Jiaotong University, Xi'an, PR China
| | - Weifeng Li
- School of Pharmacy, Xi'an Jiaotong University, Xi'an, PR China.
| | - Xiaofeng Niu
- School of Pharmacy, Xi'an Jiaotong University, Xi'an, PR China.
| |
Collapse
|